Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 3, 2008, Pages 240.e1-240.e8

  Berry, Emily ^a   Lindheim, Steven R ^b   Connor, Joseph P ^b   Hartenbach, Ellen M ^b   Schink, Julian C ^a,b   Harter, Josephine ^b   Eickhoff, Jens C ^b   Kushner, David M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

cytologic analysis; dissemination; endometrial cancer; sonohysterography

Indexed keywords

SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER INCIDENCE; CELL VIABILITY; CYTOLOGY; DISSEMINATED CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HYSTEROGRAPHY; LAPAROTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 50349083753     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.03.042     Document Type: Article

References (31)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2006. CA Cancer J Clin 56 (2006) 106-130
2. Richman T.S., Viscomi G.N., deCherney A., Polan M.L., and Alcebo L.O. Fallopian tubal patency assessed by ultrasound following fluid injection: work in progress. Radiology 152 (1984) 507-510
3. Lindheim S.R., and Sauer M.V. Upper genital tract screening with hysterosonography in patients receiving donated oocytes. Int J Gynecol Obstet 60 (1998) 47-50
4. Keltz M.D., Olive D.L., Kim A.H., and Arici A. Sonohysterography for screening in recurrent pregnancy loss. Fertil Steril 67 (1997) 670-674
5. Romano F., Cicinelli E., Anastasio P., Epifani S., Fanelli F., and Galantino P. Sonohysterography versus hysteroscopy for diagnosing endouterine abnormalities in fertile women. Int J Gynecol Obstet 45 (1994) 253-260
6. Cicinelli E., Romano F., Anastasio P., Blasi N., Parisi C., and Galantino P. Transabdominal sonohysterography, transvaginal sonography, and hysterography in the evaluation of submucous myomas. Obstet Gynecol 85 (1995) 42-47
7. Randolph J.R., Ying Y.K., Maier D.B., Schmidt C.L., and Riddick D.H. Comparison of realtime ultrasonography, hysterosalpingography, and laparoscopy/hysteroscopy in the evaluation of uterine abnormalities and tubal patency. Fertil Steril 49 (1986) 828-832
8. Saidi M.H., Sadler R.K., Theis V.D., Akright B.D., Farhart S.A., and Villaneuva G.R. Comparison of sonography, sonohysterography, and hysteroscopy for evaluation of abnormal uterine bleeding. J Ultrasound Med 16 (1997) 587-591
9. Widrich T., Bradley L.D., Mitchinson A.R., and Collins R.L. Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. Am J Obstet Gynecol 174 (1996) 1327-1334
10. Romano S., Shimoni Y., Muralee D., and Shalev E. Retrograde seeding of endometrial cancer during hysteroscopy. Gynecol Oncol 44 (1992) 116-118
11. Egarter C., Krestan C., and Kurz C. Abdominal dissemination of malignant cells with hysteroscopy. Gynecol Oncol 63 (1996) 143-144
12. Sagawa T., Yamada H., Sakuragi N., and Fujimoto S. A comparison between the preoperative and operative findings of peritoneal cytology in patients with endometrial cancer. Asia Oceania J Obstet Gynaecol 20 (1994) 39-47
13. Obermair A., Geramou M., Gucer F., et al. Does hysteroscopy facilitate tumor cell dissemination?. Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C. Cancer 88 (2000) 139-143
14. Zerbe M.J., Zhang J., Bristow R.E., Grumbine C., Abularach S., and Montz F.J. Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol Oncol 79 (2000) 55-58
15. Lo K.W., Cheung T.H., Yim S.F., and Chung T.K. Hysteroscopic dissemination of endometrial carcinoma using carbon dioxide and normal saline: a retrospective study. Gynecol Oncol 84 (2002) 394-398
16. Bradley W.H., Boente M.P., Brooker D., et al. Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol 104 (2004) 1030-1033
17. Alcazar J.L., Errasti T., and Zornoza A. Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet Gynecol Scand 79 (2000) 321-322
18. Dessole S., Rubattu G., Farina M., et al. Risks and usefulness of sonohysterography in patients with endometrial carcinoma. Am J Obstet Gynecol 194 (2006) 362-368
19. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
20. Arikan G., Reich O., Weiss U., et al. Are endometrial carcinoma cells disseminated at hysteroscopy functionally viable?. Gynecol Oncol 83 (2001) 221-226
21. Obermair A., Geramou M., Gucer F., et al. Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients. Int J Gynecol Cancer 10 (2000) 275-279
22. Sainz de la Cuesta R., Espinosa J.A., Crespo E., Granizo J.J., and Rivas F. Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer?. A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 115 (2004) 211-215
23. Creasman W.T., Disaia P.J., Blessing J., Wilkinson R.H., Johnston W., and Weed J.C. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 141 (1981) 921-929
24. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
25. Milosevic M.F., Dembo A.J., and Thomas G.M. The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma. Int J Gynecol Cancer 2 (1992) 225-235
26. Havrilesky L.J., Cragun J.M., Calingaert B., et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol 104 (2007) 401-405
27. Yazigi R., Piver M.S., and Blumenson L. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet Gynecol 62 (1983) 359-362
28. Lurain J.R., Rumsey N., Schink J.C., Wallemark C.B., and Chmiel J. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 74 (1989) 175-179
29. Kadar N., Homesley H.D., and Malfetano J.H. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 46 (1992) 145-149
30. Kasamatsu T., Onda T., Katsumata N., et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 88 (2003) 245-250
31. Tebeu P.M., Popowski Y., Verkooijen H.M., et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br J Cancer 91 (2004) 720-724